Literature DB >> 31300519

PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.

Cristina Guardia-Laguarta1,2,3, Yuhui Liu1,3, Knut H Lauritzen1,3,4, Hediye Erdjument-Bromage5, Brittany Martin1,3, Theresa C Swayne6, Xuejun Jiang7, Serge Przedborski8,2,3,6.   

Abstract

Maintaining a pool of functional mitochondria requires degradation of damaged ones within the cell. PINK1 is critical in this quality-control process: loss of mitochondrial membrane potential causes PINK1 to accumulate on the mitochondrial surface, triggering mitophagy. However, little is known about how PINK1 is regulated. Recently, we showed that PINK1 content is kept low in healthy mitochondria by continuous ubiquitination and proteasomal degradation of its mature form via a mechanism inconsistent with the proposed N-end rule process. Using both human female and monkey cell lines, we now demonstrate that once generated within the mitochondria, 52 kDa PINK1 adopts a mitochondrial topology most consistent with it being at the mitochondrial-endoplasmic reticulum (ER) interface. From this particular submitochondrial location, PINK1 interacts with components of the ER-associated degradation pathway, such as the E3 ligases gp78 and HRD1, which cooperate to catalyze PINK1 ubiquitination. The valosin-containing protein and its cofactor, UFD1, then target ubiquitinated PINK1 for proteasomal degradation. Our data show that PINK1 in healthy mitochondria is negatively regulated via an interplay between mitochondria and ER, and shed light on how this mitochondrial protein gains access to the proteasome.SIGNIFICANCE STATEMENT Regulation of mitochondrial content of PINK1, a contributor to mitophagy, is an important area of research. Recently, we found that PINK1 content is kept low in healthy mitochondria by continuous ubiquitination and proteasomal degradation. We now extend and refine this novel finding by showing that PINK1 localizes at the mitochondrial-endoplasmic reticulum (ER) interface, from where it interacts with the ER-associated degradation machinery, which catalyzes its ubiquitination and transfer to the proteasome. Thus, these data show that PINK1 in healthy mitochondria is negatively regulated via a mitochondria and ER interplay, and how this mitochondrial protein gains access to the proteasome.
Copyright © 2019 the authors.

Entities:  

Keywords:  ERAD; PINK1; Parkinson's disease; mitochondria; proteasome; ubiquitination

Mesh:

Substances:

Year:  2019        PMID: 31300519      PMCID: PMC6733537          DOI: 10.1523/JNEUROSCI.1691-18.2019

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  74 in total

1.  A HECT domain E3 enzyme assembles novel polyubiquitin chains.

Authors:  J You; C M Pickart
Journal:  J Biol Chem       Date:  2001-03-14       Impact factor: 5.157

2.  A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly.

Authors:  M Koegl; T Hoppe; S Schlenker; H D Ulrich; T U Mayer; S Jentsch
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

3.  The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol.

Authors:  Y Ye; H H Meyer; T A Rapoport
Journal:  Nature       Date:  2001-12-06       Impact factor: 49.962

Review 4.  Genetics of Parkinson's disease.

Authors:  V Bonifati
Journal:  Minerva Med       Date:  2005-06       Impact factor: 4.806

Review 5.  Parkinson's disease: mechanisms and models.

Authors:  William Dauer; Serge Przedborski
Journal:  Neuron       Date:  2003-09-11       Impact factor: 17.173

6.  Definitive evidence for Ufd2-catalyzed elongation of the ubiquitin chain through Lys48 linkage.

Authors:  Yasushi Saeki; Yoko Tayama; Akio Toh-e; Hideyoshi Yokosawa
Journal:  Biochem Biophys Res Commun       Date:  2004-07-30       Impact factor: 3.575

Review 7.  Role of N-linked polymannose oligosaccharides in targeting glycoproteins for endoplasmic reticulum-associated degradation.

Authors:  R G Spiro
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

8.  Ubiquitin-mediated fluorescence complementation reveals that Jun ubiquitinated by Itch/AIP4 is localized to lysosomes.

Authors:  Deyu Fang; Tom K Kerppola
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-05       Impact factor: 11.205

9.  Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism.

Authors:  Laura Silvestri; Viviana Caputo; Emanuele Bellacchio; Luigia Atorino; Bruno Dallapiccola; Enza Maria Valente; Giorgio Casari
Journal:  Hum Mol Genet       Date:  2005-10-05       Impact factor: 6.150

10.  Hereditary early-onset Parkinson's disease caused by mutations in PINK1.

Authors:  Enza Maria Valente; Patrick M Abou-Sleiman; Viviana Caputo; Miratul M K Muqit; Kirsten Harvey; Suzana Gispert; Zeeshan Ali; Domenico Del Turco; Anna Rita Bentivoglio; Daniel G Healy; Alberto Albanese; Robert Nussbaum; Rafael González-Maldonado; Thomas Deller; Sergio Salvi; Pietro Cortelli; William P Gilks; David S Latchman; Robert J Harvey; Bruno Dallapiccola; Georg Auburger; Nicholas W Wood
Journal:  Science       Date:  2004-04-15       Impact factor: 47.728

View more
  15 in total

1.  Apelin-36 Protects HT22 Cells Against Oxygen-Glucose Deprivation/Reperfusion-Induced Oxidative Stress and Mitochondrial Dysfunction by Promoting SIRT1-Mediated PINK1/Parkin-Dependent Mitophagy.

Authors:  Ziqi Shao; Shanshan Dou; Junge Zhu; Huiqing Wang; Dandan Xu; Chunmei Wang; Baohua Cheng; Bo Bai
Journal:  Neurotox Res       Date:  2021-02-13       Impact factor: 3.911

Review 2.  Mitochondrial Quality and Quantity Control: Mitophagy Is a Potential Therapeutic Target for Ischemic Stroke.

Authors:  Meiying Song; Yuan Zhou; Xiang Fan
Journal:  Mol Neurobiol       Date:  2022-03-09       Impact factor: 5.590

3.  Mitochondria in neurodegeneration.

Authors:  Charleen T Chu
Journal:  Curr Opin Physiol       Date:  2022-04-01

4.  PINK1: Multiple mechanisms of neuroprotection.

Authors:  Britney N Lizama; P Anthony Otero; Charleen T Chu
Journal:  Int Rev Mov Disord       Date:  2021-10-04

5.  Inter-organellar Communication in Parkinson's and Alzheimer's Disease: Looking Beyond Endoplasmic Reticulum-Mitochondria Contact Sites.

Authors:  Stephanie Vrijsen; Céline Vrancx; Mara Del Vecchio; Johannes V Swinnen; Patrizia Agostinis; Joris Winderickx; Peter Vangheluwe; Wim Annaert
Journal:  Front Neurosci       Date:  2022-06-21       Impact factor: 5.152

Review 6.  PINK1/PARKIN signalling in neurodegeneration and neuroinflammation.

Authors:  Peter M J Quinn; Paula I Moreira; António Francisco Ambrósio; C Henrique Alves
Journal:  Acta Neuropathol Commun       Date:  2020-11-09       Impact factor: 7.801

Review 7.  The Mitochondrial Kinase PINK1 in Diabetic Kidney Disease.

Authors:  Chunling Huang; Ji Bian; Qinghua Cao; Xin-Ming Chen; Carol A Pollock
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

Review 8.  Emerging role of VCP/p97 in cardiovascular diseases: novel insights and therapeutic opportunities.

Authors:  Hongyang Shu; Yizhong Peng; Weijian Hang; Ning Zhou; Dao Wen Wang
Journal:  Biochem Soc Trans       Date:  2021-02-26       Impact factor: 5.407

9.  Impaired mitochondrial-endoplasmic reticulum interaction and mitophagy in Miro1-mutant neurons in Parkinson's disease.

Authors:  Clara Berenguer-Escuder; Dajana Grossmann; Paul Antony; Giuseppe Arena; Kobi Wasner; François Massart; Javier Jarazo; Jonas Walter; Jens C Schwamborn; Anne Grünewald; Rejko Krüger
Journal:  Hum Mol Genet       Date:  2020-05-28       Impact factor: 6.150

10.  RIPC provides neuroprotection against ischemic stroke by suppressing apoptosis via the mitochondrial pathway.

Authors:  Jing Lv; Weikang Guan; Qiang You; Li Deng; Yan Zhu; Kan Guo; Xiaoqing Gao; Jiming Kong; Chaoxian Yang
Journal:  Sci Rep       Date:  2020-03-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.